Literature DB >> 3786143

Nucleotide sequence of the gene encoding the matrix protein of Newcastle disease virus.

P Chambers, N S Millar, S G Platt, P T Emmerson.   

Abstract

The nucleotide sequence of the gene encoding the matrix (M) protein of the Beaudette C strain of Newcastle disease virus (NDV) has been determined from overlapping cDNA clones. Control sequences typical of paramyxovirus mRNA start and polyadenylation signals have been identified. Assuming that the M gene starts and finishes at these sequences, the M gene is 1241 nucleotides long and encodes one long open reading frame of 364 amino acids, corresponding to a polypeptide of molecular weight 39605, in good agreement with estimates from SDS gels. The M protein has an amino acid sequence that is both hydrophobic and highly basic. The NDV M protein has sequence homologies to the M proteins of Sendai, measles, canine distemper and respiratory syncytial viruses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3786143      PMCID: PMC311928          DOI: 10.1093/nar/14.22.9051

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  The smallest protein of Sendi virus: its candidate function of binding nucleocaspsid to envelope.

Authors:  K Shimizu; N Isida
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

2.  The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

3.  A morphological study of the M-protein of Sendai virus.

Authors:  J A Hewitt; M V Nermut
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

Review 4.  Virulence in Newcastle disease virus. A preliminary study.

Authors:  A P Waterson; T H Pennington; W H Allan
Journal:  Br Med Bull       Date:  1967-05       Impact factor: 4.291

5.  Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins.

Authors:  J Garnier; D J Osguthorpe; B Robson
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

6.  Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking.

Authors:  M A Markwell; C F Fox
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Protein organization in Newcastle disease virus as revealed by perturbant treatment.

Authors:  J K Li; T Miyakawa; C F Fox
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

8.  A new structural protein for Newcastle disease virus.

Authors:  P Chambers; A C Samson
Journal:  J Gen Virol       Date:  1980-09       Impact factor: 3.891

9.  Identification of the P proteins and other disulfide-linked and phosphorylated proteins of Newcastle disease virus.

Authors:  G W Smith; L E Hightower
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

10.  Interaction of Sendai virus proteins with the cytoplasmic surface of erythrocyte membranes following viral envelope fusion.

Authors:  S E Caldwell; D S Lyles
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  12 in total

1.  Sequence analysis of temperature sensitive and "neuraminidase-tolerant" mutants of Newcastle disease virus (strain Beaudette C).

Authors:  J Hughes; K Yusoff; R Hardy; H McCartney; P T Emmerson; A C Samson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Nucleotide sequence of the human parainfluenza virus 3 matrix protein gene.

Authors:  K Prinoski; M J Côté; C Y Kang; K Dimock
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

3.  Coordinate deletion of N-glycans from the heptad repeats of the fusion F protein of Newcastle disease virus yields a hyperfusogenic virus with increased replication, virulence, and immunogenicity.

Authors:  Sweety Samal; Sunil K Khattar; Sachin Kumar; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

4.  Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins.

Authors:  Y Sakai; S Suzu; T Shioda; H Shibuta
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

5.  Nucleotide sequence analysis of the L gene of Newcastle disease virus: homologies with Sendai and vesicular stomatitis viruses.

Authors:  K Yusoff; N S Millar; P Chambers; P T Emmerson
Journal:  Nucleic Acids Res       Date:  1987-05-26       Impact factor: 16.971

6.  Molecular evolution of human paramyxoviruses. Nucleotide sequence analyses of the human parainfluenza type 1 virus NP and M protein genes and construction of phylogenetic trees for all the human paramyxoviruses.

Authors:  K Miyahara; S Kitada; M Yoshimoto; H Matsumura; M Kawano; H Komada; M Tsurudome; S Kusagawa; M Nishio; Y Ito
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Analysis of matrix protein gene nucleotide sequence diversity among Newcastle disease virus isolates demonstrates that recent disease outbreaks are caused by viruses of psittacine origin.

Authors:  B S Seal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

8.  Characterization of Newcastle disease virus isolates by reverse transcription PCR coupled to direct nucleotide sequencing and development of sequence database for pathotype prediction and molecular epidemiological analysis.

Authors:  B S Seal; D J King; J D Bennett
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

9.  The large polymerase protein is associated with the virulence of Newcastle disease virus.

Authors:  Subrat N Rout; Siba K Samal
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

10.  Matrix protein gene sequence analysis of avian paramyxovirus 1 isolates obtained from pigeons.

Authors:  Flavia Zanetti; Marianela Rodríguez; Daniel J King; Ilaria Capua; Elisa Carrillo; Bruce S Seal; Analía Berinstein
Journal:  Virus Genes       Date:  2003       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.